{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:34:49Z","timestamp":1785800089965,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1146134"],"award-info":[{"award-number":["APP1146134"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.gim.2023.100813","type":"journal-article","created":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T14:50:17Z","timestamp":1676213417000},"page":"100813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Economic evaluation of population-based, expanded reproductive carrier screening for genetic diseases in\u00a0Australia"],"prefix":"10.1016","volume":"25","author":[{"given":"Deborah","family":"Schofield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4434-1304","authenticated-orcid":false,"given":"Evelyn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayamala","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Laing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Mumford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupendra","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gim.2023.100813_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ajmg.1320210205","article-title":"The effect of Mendelian disease on human health: a measurement","volume":"21","author":"Costa","year":"1985","journal-title":"Am J Med Genet"},{"issue":"8","key":"10.1016\/j.gim.2023.100813_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0025-6196(11)63220-5","article-title":"Prevalence and patterns of presentation of genetic disorders in a pediatric emergency department","volume":"76","author":"Kumar","year":"2001","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.gim.2023.100813_bib3","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.tig.2019.08.006","article-title":"Toward clinical implementation of next-generation sequencing-based genetic testing in rare diseases: where are we?","volume":"35","author":"Liu","year":"2019","journal-title":"Trends Genet"},{"issue":"11","key":"10.1016\/j.gim.2023.100813_bib4","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/gim.2018.17","article-title":"Genetic disorders and mortality in infancy and early childhood: delayed diagnoses and missed opportunities","volume":"20","author":"Wojcik","year":"2018","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.gim.2023.100813_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/gim.2013.47","article-title":"ACMG position statement on prenatal\/preconception expanded carrier screening","volume":"15","author":"Grody","year":"2013","journal-title":"Genet Med"},{"issue":"suppl 3","key":"10.1016\/j.gim.2023.100813_bib6","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1007\/PL00014401","article-title":"Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model","volume":"159","author":"Kaback","year":"2000","journal-title":"Eur J Pediatr"},{"issue":"9","key":"10.1016\/j.gim.2023.100813_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41576-019-0134-2","article-title":"Carrier screening for recessive disorders","volume":"20","author":"Antonarakis","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10.1016\/j.gim.2023.100813_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0889-8545(01)00006-7","article-title":"Screening for thalassemia: a model of success","volume":"29","author":"Cao","year":"2002","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"10","key":"10.1016\/j.gim.2023.100813_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/pd.4647","article-title":"Changing trends in carrier screening for genetic disease in the United States","volume":"35","author":"Nazareth","year":"2015","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.gim.2023.100813_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/gim.2012.114","article-title":"An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals","volume":"15","author":"Lazarin","year":"2013","journal-title":"Genet Med"},{"issue":"7","key":"10.1016\/j.gim.2023.100813_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.2016.11139","article-title":"Modeled fetal risk of genetic diseases identified by expanded carrier screening","volume":"316","author":"Haque","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.gim.2023.100813_bib12","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41436-018-0273-4","article-title":"The evolving landscape of expanded carrier screening: challenges and opportunities","volume":"21","author":"Kraft","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2023.100813_bib13","doi-asserted-by":"crossref","unstructured":"Gregg AR, Aarabi M, Klugman S, et\u00a0al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(10):1793-1806. Published correction appears in Genet Med. 2021;23(10):2015. http:\/\/doi.org\/10.1038\/s41436-021-01203-z","DOI":"10.1038\/s41436-021-01203-z"},{"issue":"1","key":"10.1016\/j.gim.2023.100813_bib15","first-page":"21","article-title":"Expanded universal carrier screening and its implementation within a publicly funded healthcare service","volume":"11","author":"Rowe","year":"2020","journal-title":"J\u00a0Community Genet"},{"issue":"2","key":"10.1016\/j.gim.2023.100813_bib16","first-page":"191","article-title":"Expanded carrier screening panels-does bigger mean better?","volume":"5","author":"Wienke","year":"2014","journal-title":"J\u00a0Community Genet"},{"issue":"4","key":"10.1016\/j.gim.2023.100813_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5694\/mja2.50789","article-title":"Ethical issues in reproductive genetic carrier screening","volume":"214","author":"Dive","year":"2021","journal-title":"Med J Aust"},{"key":"10.1016\/j.gim.2023.100813_bib18","doi-asserted-by":"crossref","unstructured":"Beauchamp KA, Johansen Taber KA, Muzzey D. Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen. Genet Med. 2019;21(9):1948-1957. Published correction appears in Genet Med. 2022;24(4):968. http:\/\/doi.org\/10.1038\/s41436-019-0455-8","DOI":"10.1038\/s41436-019-0455-8"},{"key":"10.1016\/j.gim.2023.100813_bib19","doi-asserted-by":"crossref","unstructured":"Zhang L, Bao Y, Riaz M, et\u00a0al. Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis. Genet Med. 2019;21(9):1958-1968. Published correction appears in Genet Med. 2019;21(9):2162-2163. http:\/\/doi.org\/10.1038\/s41436-019-0457-6","DOI":"10.1038\/s41436-019-0515-0"},{"issue":"2","key":"10.1016\/j.gim.2023.100813_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14737167.2022.1993063","article-title":"Economic evaluation of reproductive carrier screening for recessive genetic conditions: a systematic review","volume":"22","author":"Wang","year":"2022","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.gim.2023.100813_bib21","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"key":"10.1016\/j.gim.2023.100813_bib22","unstructured":"Commonwealth of Australia, Australian Bureau of Statistics. 2071.0 - Census of Population and Housing: Reflecting Australia - Stories from the Census, 2016. Accessed December 11, 2019. https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Lookup\/by%20Subject\/2071.0\u223c2016\u223cMain%20Features\u223cSnapshot%20of%20Australia,%202016\u223c2"},{"key":"10.1016\/j.gim.2023.100813_bib23","unstructured":"Commonwealth of Australia, Australian Bureau of Statistics. 3302.0.55.001 - Life Tables, States, Territories and Australia, 2015-2017. Accessed January 30, 2022. https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Lookup\/by%20Subject\/2071.0\u223c2016\u223cMain%20Features\u223cSnapshot%20of%20Australia,%202016\u223c2"},{"issue":"1","key":"10.1016\/j.gim.2023.100813_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12955-016-0537-0","article-title":"Health-related quality of life measured using the EQ-5D-5L: South Australian population norms","volume":"14","author":"McCaffrey","year":"2016","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"10.1016\/j.gim.2023.100813_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/gim.2013.125","article-title":"Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research","volume":"16","author":"Ioannou","year":"2014","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.gim.2023.100813_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/humupd\/dmaa001","article-title":"Interest in expanded carrier screening among individuals and couples in the general population: systematic review of the literature","volume":"26","author":"Van Steijvoort","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.gim.2023.100813_bib27","doi-asserted-by":"crossref","unstructured":"Archibald AD, Smith MJ, Burgess T, et\u00a0al. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests. Genet Med. 2018;20(5):513-523. Published correction appears in Genet Med. 2018;20(11):1485. http:\/\/doi.org\/10.1038\/gim.2017.134","DOI":"10.1038\/gim.2017.266"},{"issue":"3","key":"10.1016\/j.gim.2023.100813_bib28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/mgg3.204","article-title":"Carrier screening by next-generation sequencing: health benefits and cost effectiveness","volume":"4","author":"Azimi","year":"2016","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"10.1016\/j.gim.2023.100813_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/humrep\/12.2.341","article-title":"Preimplantation diagnosis and other reproductive options: attitudes of male and female carriers of recessive disorders","volume":"12","author":"Snowdon","year":"1997","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.gim.2023.100813_bib30","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41436-018-0321-0","article-title":"Clinical utility of expanded carrier screening: results-guided actionability and outcomes","volume":"21","author":"Taber","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2023.100813_bib31","author":"Fitzgerald"},{"issue":"2","key":"10.1016\/j.gim.2023.100813_bib32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/humrep\/deu303","article-title":"The clinical effectiveness of preimplantation genetic diagnosis for aneuploidy in all 24 chromosomes (PGD-A): systematic review","volume":"30","author":"Lee","year":"2015","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.gim.2023.100813_bib33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.fertnstert.2019.05.012","article-title":"Oocyte donor age has a significant impact on oocyte recipients\u2019 cumulative live-birth rate: a population-based cohort study","volume":"112","author":"Hogan","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gim.2023.100813_bib34","unstructured":"Australian Government Department of Health and Aged Care. The Pharmaceutical Benefits Advisory Committee (PBAC) guidelines. Pharmaceutical benefits Advisory Cimmittee. Published September 2016. Accessed May 22, 2022. https:\/\/pbac.pbs.gov.au"},{"key":"10.1016\/j.gim.2023.100813_bib35","unstructured":"Commonwealth of Australia, Australian Bureau of Statistics. 3301.0 - Births, Australia, 2016 Australian Bureau of Statistics. Published December 13, 2017. Accessed December 11, 2019. https:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/Lookup\/3301.0Main+Features12016?OpenDocument="},{"issue":"4","key":"10.1016\/j.gim.2023.100813_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5694\/j.1326-5377.2006.tb00174.x","article-title":"Assisted reproductive technology treatment costs of a live birth: an age-stratified cost\u2013outcome study of treatment in Australia","volume":"184","author":"Chambers","year":"2006","journal-title":"Med J Aust"},{"issue":"4","key":"10.1016\/j.gim.2023.100813_bib40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/ajo.12988","article-title":"A\u00a0cost-effectiveness analysis of preimplantation genetic testing for aneuploidy (PGT-A) for up to three complete assisted reproductive technology cycles in women of advanced maternal age","volume":"59","author":"Lee","year":"2019","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.gim.2023.100813_bib42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/0272989X12454579","article-title":"Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force\u20137","volume":"32","author":"Eddy","year":"2012","journal-title":"Med Decis Making"},{"issue":"2","key":"10.1016\/j.gim.2023.100813_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14737167.8.2.165","article-title":"Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold","volume":"8","author":"Grosse","year":"2008","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"10.1016\/j.gim.2023.100813_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.siny.2018.09.004","article-title":"Health economic aspects of late preterm and early term birth","volume":"24","author":"Petrou","year":"2019","journal-title":"Semin Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.gim.2023.100813_bib45","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/GIM.0b013e3181837217","article-title":"Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis","volume":"10","author":"Grosse","year":"2008","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.gim.2023.100813_bib46","first-page":"7","article-title":"Comparative cancer incidence, mortality and survival in Indigenous and non-indigenous residents of South Australia and the Northern Territory","volume":"29","author":"Roder","year":"2005","journal-title":"Cancer Forum"},{"issue":"3","key":"10.1016\/j.gim.2023.100813_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1467-842X.2001.tb00573.x","article-title":"Cervical screening by socio-economic status in Australia","volume":"25","author":"Taylor","year":"2001","journal-title":"Aust N Z J Public Health"},{"issue":"1","key":"10.1016\/j.gim.2023.100813_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1479-828X.2010.01250.x","article-title":"Socio-demographic disparities in the uptake of prenatal screening and diagnosis in Western Australia","volume":"51","author":"Maxwell","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.gim.2023.100813_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12939-019-0931-4","article-title":"Long-term out of pocket expenditure of people with cancer: comparing health service cost and use for indigenous and non-indigenous people with cancer in Australia","volume":"18","author":"Callander","year":"2019","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.gim.2023.100813_bib50","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1472-6963-12-142","article-title":"A\u00a0reduction in public funding for fertility treatment-an econometric analysis of access to treatment and savings to government","volume":"12","author":"Chambers","year":"2012","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"10.1016\/j.gim.2023.100813_bib51","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1373\/clinchem.2018.286823","article-title":"Validation of an expanded carrier screen that optimizes sensitivity via full-exon sequencing and panel-wide copy number variant identification","volume":"64","author":"Hogan","year":"2018","journal-title":"Clin Chem"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360023008262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360023008262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T23:03:43Z","timestamp":1727823823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360023008262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1098360023008262"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2023.100813","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic evaluation of population-based, expanded reproductive carrier screening for genetic diseases in\u00a0Australia","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2023.100813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"100813"}}